You Are the Reason We Exist.
We Value Life.

Fidson Healthcare Plc. is the leading pharmaceutical company in Nigeria engaged in the business of manufacturing, marketing, and sales of pharmaceutical and healthcare products. We are a wholly Nigerian company that has grown to become a leading player in the West African healthcare landscape.

Though it started as a local distributor of pharmaceutical products, the company has relentlessly pursued its goal to become the leading player in the pharmaceutical and Healthcare ecosystem in West Africa. Our core values – Innovation, Excellence, Passion, Integrity, and Ownership – form the backbone on which we have built a world-class company that has earned the respect and admiration of even the fiercest of our competitors.

We currently run a CGMP compliant manufacturing facility and are one of a few Nigerian pharmaceutical manufacturers that are candidates for the WHO GMP certification. We have left no stone unturned to ensure that our operations go well together with the best of practices globally. To deliver unique products and cost-effective services, the company is also into technical collaborations with various overseas manufacturers, most of whom are market leaders in their areas of specialization. Today we are the largest employer of pharmacists in Nigeria outside of the Government and one of the most respected healthcare companies in Sub-Saharan Africa

Fidson

Our History

Fidson Healthcare Plc. was incorporated in March 1995 and has grown to become the leading pharmaceutical company in Nigeria.
Though it started as a local distributor of pharmaceutical products, the company has relentlessly pursued its goal to become the leading player in the pharmaceutical and Healthcare ecosystem in West Africa. Our core values – Innovation, Excellence, Passion, Integrity, and Ownership – form the backbone on which we have built a world-class company that has earned the respect and admiration of even the fiercest of our competitors.
Barely a year into its existence, Fidson started the importation of its own brands of finished medicines – introducing Ciprotab and Peflotab brands of quinolones to the market. By July 2002, Fidson set up its first local manufacturing facility and later became the first company in sub-Saharan Africa to manufacture Antiretroviral (ARV) drugs in March 2005.
Expanding its business even further, Fidson was listed on the floor of the Nigerian Stock Exchange, (NSE) to become a publicly quoted company in 2008 and completed its 3rd Factory in the same year. About a year later, the company won the Financial Standard Sector Leader Award.
With a Market Capitalization of 36.5 billion Naira, Fidson has become the largest pharmaceutical company in the healthcare sector of the NSE. The company reported a turnover of ₦53.05billion for the year ended 31 December 2023.
Today, we manufacture ten (10) distinct dosage forms from our ultramodern, World Health Organisation Current Good Manufacturing Practice (WHO cGMP) certifiable factory in Ota, Ogun State and are a distinguished candidate for pre-qualification by WHO.
By leveraging our relationships and collaborations with various international technical partners – most of whom are market leaders in their areas of specializations – we can deliver high-quality medicines to Africa. Today, we offer over 350 NAFDAC registered brands including POMs & OTCs across various therapeutic classes and pharmacological segments. We also provide excellent services including research, formulation & development, and contract manufacturing.
Fidson prides itself in quality and technical excellence and had received the NIS ISO 9001:2000 certification for Quality Management Systems from the Standards Organization of Nigeria (SON) in November 2017. This has subsequently been upgraded to NIS ISO 9001:2015. Also, in 2019, we received the NIS ISO 14001: 2015 certification for our excellent Environmental Management Systems and still retained the certification following the successful recertification audit conducted in December 2021 that conferred compliant status of the company in accordance with current management system requirements. We are the only company in our sector to achieve this feat. We are currently the sole manufacturing partner for GSK and Bayer in Nigeria.

Vision

To be the preferred healthcare provider

Mission

To be the preferred company that adds value to life with brands that deliver sustainable, profitable growth

Our Brand Essence

The focus of our services is the commitment to a better life for all people. This reflects in our array of products and the way we manufacture them as well as how we interact with the society – preserve our mantra …We Value Life.

Ultimately, Fidson is the family-friendly company whose paramount objective remains the wellbeing of the lives we touch.

Core Values

Innovation

Our creativity, resourcefulness, and penchant for problem-solving is uncompromised.

Excellence

Our unreserved consistency in quality of delivery and high
performance ensures that we exceed expectations.

Passion

Our dedication and enterprising propensity drives us to deliver exceptional results in everything we do.

Ownership

We display initiative, exercising possession and control of activities and tasks with a positive attitude.

Integrity

Trustworthiness and upholding ethics and professionalism are some of our hallmarks.

Milestone

1995

Incorporation and commenced operations as a
local drug distributor.

2002

Commissioned our first factory, becoming Nigeria's first PPI manufacturer.

2005

1st Local manufacturer of ARVs in Nigeria

2006

Completed 2nd manufacturing plant in Ota, Nigeria

2007 & 2008

NIS ISO
9001:2000
Certification

Raised N3.5b via
Private Placement

Listed on the
NSE in 2008

20011 & 2012

Became ISO 9001 :
2008 certified

Nigerian Stock
Exchange CEO of the Year

2014

Nigerian Healthcare Excellence Awards

BusinessDay Top 25 CEO Awards – 2013 & 2014

Raised N2bn via a publicly quoted Bond Issue

2015

Frost & Sullivan Growth, Innovation
Excellence Awards 2014

BusinessDay Top 25
CEO Awards – 2015

2016

WHO Compliant Manufacturing Facility Commissioned

2018

Frost & Sullivan Pharmaceutical
Production Competitive
Strategy Award
2018

2019+

EMS ISO 14001:2015
Certification

Raised N2.3b via Rights Issue

Appointed by GSK as local
manufacturing partner

Strategic partnership with
Ohara, Japan.

2020

Expansion Product Innovation Exports.

2021

Commenced Contract Manufacturing For GSK

Signed Contract Manufacturing partnership with
Bayer AG Exports

2022

NECA’s Best Employer
Pharmaceutical & HMO

IAS Pharma Manufacturing
Excellence Awards

Best Performing Stock in the
Healthcare sector (NGX)

2023 & 2024

Signed agreement with Serum
Institute of India for Malaria Vaccine

Pioneered ampoule injection
manufacturing in Nigeria Pharma Industry